DC
ACET icon

Diametric Capital’s Adicet Bio ACET Stock Holding History

Diametric Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,345
Closed -$82.3K – 210
2024
Q4 		$82.3K Sell
5,345
-1,516
-22% -$28.6K 0.06% 279
2024
Q3 		$158K Buy
+6,861
New +$154K 0.08% 321

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Diametric Capital's ACET Position: Q1 2025 in Review

Diametric Capital sold out of Adicet Bio (ACET) in Q1 2025, closing a stake of 5,345 shares — an estimated $82.3K sold.

Diametric Capital first reported a position in ACET in Q3 2024 and held it in 2 quarters. The position peaked at $158K in Q3 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q1 2025.

  • Diametric Capital reported no remaining Adicet Bio position as of Q1 2025 after selling out during the quarter.
  • Diametric Capital sold 5,345 Adicet Bio shares in Q1 2025, an estimated $82.3K.
  • Diametric Capital first reported a position in Adicet Bio in Q3 2024 and held it in 2 quarters.
  • Diametric Capital's Adicet Bio position peaked at $158K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2025.

Based on Diametric Capital's 13F filing for Q1 2025, filed 14 May 2025.